{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:39:19Z","timestamp":1709685559003},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,5]]},"DOI":"10.7759\/cureus.55575","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T16:10:31Z","timestamp":1709655031000},"source":"Crossref","is-referenced-by-count":0,"title":["Three Siblings With a Rare Familial Hyperphosphatemia Syndrome: A Case Series"],"prefix":"10.7759","author":[{"given":"Zaid A","family":"Sowaity","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaber Y","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayseer N","family":"Sabooh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama N","family":"Dukmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sima Y","family":"Abu Al-Saoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-006-0377-6","article-title":"Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred","volume":"51","author":"Specktor P","year":"2006","unstructured":"Specktor P, Cooper JG, Indelman M, Sprecher E. Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred. J Hum Genet. 2006, 51:487-90. 10.1007\/s10038-006-0377-6","journal-title":"J Hum Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.24953\/turkjped.2019.01.022","article-title":"Recessive mutation in GALNT3 causes hyperphosphatemic familial tumoral calcinosis associated with chronic recurrent multifocal osteomyelitis","volume":"61","author":"Albaramki J","year":"2019","unstructured":"Albaramki J, Dmour H, Shboul M, Bonnard C, Venkatesh B, Odeh R. Recessive mutation in GALNT3 causes hyperphosphatemic familial tumoral calcinosis associated with chronic recurrent multifocal osteomyelitis. Turk J Pediatr. 2019, 61:130-3. 10.24953\/turkjped.2019.01.022","journal-title":"Turk J Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00293","article-title":"Hyperphosphatemic tumoral calcinosis: pathogenesis, clinical presentation, and challenges in management","volume":"11","author":"Boyce AM","year":"2020","unstructured":"Boyce AM, Lee AE, Roszko KL, Gafni RI. Hyperphosphatemic tumoral calcinosis: pathogenesis, clinical presentation, and challenges in management. Front Endocrinol. 2020, 11:293. 10.3389\/fendo.2020.00293","journal-title":"Front Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-004-0610-8","article-title":"Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders","volume":"83","author":"Frishberg Y","year":"2005","unstructured":"Frishberg Y, Topaz O, Bergman R, et al.. Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders. J Mol Med. 2005, 83:33-8. 10.1007\/s00109-004-0610-8","journal-title":"J Mol Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2011.10.020","article-title":"Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and \u03b1Klotho)","volume":"25","author":"Farrow EG","year":"2011","unstructured":"Farrow EG, Imel EA, White KE. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and \u03b1Klotho). Best Pract Res Clin Rheumatol. 2011, 25:735-47. 10.1016\/j.berh.2011.10.020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-009-0808-5","article-title":"Familial tumoral calcinosis and hyperostosis-hyperphosphataemia syndrome are different manifestations of the same disease: novel missense mutations in GALNT3","volume":"39","author":"Joseph L","year":"2010","unstructured":"Joseph L, Hing SN, Presneau N, et al.. Familial tumoral calcinosis and hyperostosis-hyperphosphataemia syndrome are different manifestations of the same disease: novel missense mutations in GALNT3. Skeletal Radiol. 2010, 39:63-8. 10.1007\/s00256-009-0808-5","journal-title":"Skeletal Radiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12863-014-0098-3","article-title":"Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature","volume":"15","author":"Rafaelsen S","year":"2014","unstructured":"Rafaelsen S, Johansson S, R\u00e6der H, Bjerknes R. Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature. BMC Genet. 2014, 15:98. 10.1186\/s12863-014-0098-3","journal-title":"BMC Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2018.2018.0134","article-title":"Hyperphosphatemic familial tumoral calcinosis in two siblings with a novel mutation in GALNT3 gene: experience from southern Turkey","volume":"11","author":"K\u0131\u015fla Ekinci RM","year":"2019","unstructured":"K\u0131\u015fla Ekinci RM, G\u00fcrb\u00fcz F, Balc\u0131 S, et al.. Hyperphosphatemic familial tumoral calcinosis in two siblings with a novel mutation in GALNT3 gene: experience from southern Turkey. J Clin Res Pediatr Endocrinol. 2019, 11:94-9. 10.4274\/jcrpe.galenos.2018.2018.0134","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013111209","article-title":"The kidney is the principal organ mediating klotho effects","volume":"25","author":"Lindberg K","year":"2014","unstructured":"Lindberg K, Amin R, Moe OW, et al.. The kidney is the principal organ mediating klotho effects. J Am Soc Nephrol. 2014, 25:2169-75. 10.1681\/ASN.2013111209","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4574-x","article-title":"Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature","volume":"29","author":"Chakhtoura M","year":"2018","unstructured":"Chakhtoura M, Ramnitz MS, Khoury N, et al.. Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature. Osteoporos Int. 2018, 29:1987-2009. 10.1007\/s00198-018-4574-x","journal-title":"Osteoporos Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00267","article-title":"Physiological actions of fibroblast growth factor-23","volume":"9","author":"Erben RG","year":"2018","unstructured":"Erben RG. Physiological actions of fibroblast growth factor-23. Front Endocrinol. 2018, 9:267. 10.3389\/fendo.2018.00267","journal-title":"Front Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0011","article-title":"A novel missense mutation in GALNT3 causing hyperostosis-hyperphosphataemia syndrome","volume":"158","author":"Olauson H","year":"2008","unstructured":"Olauson H, Krajisnik T, Larsson C, Lindberg B, Larsson TE. A novel missense mutation in GALNT3 causing hyperostosis-hyperphosphataemia syndrome. Eur J Endocrinol. 2008, 158:929-34. 10.1530\/EJE-08-0011","journal-title":"Eur J Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-005-0026-8","article-title":"A novel homozygous missense mutation in FGF23 causes familial tumoral calcinosis associated with disseminated visceral calcification","volume":"118","author":"Chefetz I","year":"2005","unstructured":"Chefetz I, Heller R, Galli-Tsinopoulou A, et al.. A novel homozygous missense mutation in FGF23 causes familial tumoral calcinosis associated with disseminated visceral calcification. Hum Genet. 2005, 118:261-6. 10.1007\/s00439-005-0026-8","journal-title":"Hum Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.892113","article-title":"Hyperphosphatemic familial tumoral calcinosis: odontostomatologic management and pathological features","volume":"15","author":"Favia G","year":"2014","unstructured":"Favia G, Lacaita MG, Limongelli L, Tempesta A, Laforgia N, Cazzolla AP, Maiorano E. Hyperphosphatemic familial tumoral calcinosis: odontostomatologic management and pathological features. Am J Case Rep. 2014, 15:569-75. 10.12659\/AJCR.892113","journal-title":"Am J Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36476","article-title":"Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms","volume":"164A","author":"Finer G","year":"2014","unstructured":"Finer G, Price HE, Shore RM, White KE, Langman CB. Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms. Am J Med Genet A. 2014, 164A:1545-9. 10.1002\/ajmg.a.36476","journal-title":"Am J Med Genet A"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000197876","article-title":"Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer","volume":"71","author":"Lammoglia JJ","year":"2009","unstructured":"Lammoglia JJ, Mericq V. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer. Horm Res. 2009, 71:178-84. 10.1159\/000197876","journal-title":"Horm Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107905","article-title":"Inhibition of carbonic anhydrase by parathyroid hormone and cyclic AMP in rat renal cortex in vitro","volume":"55","author":"Beck N","year":"1975","unstructured":"Beck N, Kim KS, Wolak M, Davis BB. Inhibition of carbonic anhydrase by parathyroid hormone and cyclic AMP in rat renal cortex in vitro. J Clin Invest. 1975, 55:149-56. 10.1172\/JCI107905","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-008-0775-z","article-title":"A case of familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features","volume":"20","author":"Dumitrescu CE","year":"2009","unstructured":"Dumitrescu CE, Kelly MH, Khosravi A, et al.. A case of familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features. Osteoporos Int. 2009, 20:1273-8. 10.1007\/s00198-008-0775-z","journal-title":"Osteoporos Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-3945-z","article-title":"Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?","volume":"33","author":"Claramunt-Taberner D","year":"2018","unstructured":"Claramunt-Taberner D, Bertholet-Thomas A, Carlier MC, Dijoud F, Chotel F, Silve C, Bacchetta J. Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?. Pediatr Nephrol. 2018, 33:1263-7. 10.1007\/s00467-018-3945-z","journal-title":"Pediatr Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/193160-three-siblings-with-a-rare-familial-hyperphosphatemia-syndrome-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T16:10:33Z","timestamp":1709655033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/193160-three-siblings-with-a-rare-familial-hyperphosphatemia-syndrome-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.55575","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,5]]}}}